ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ASXSF Elysee Development Corp (PK)

0.23824
0.04154 (21.12%)
23 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Elysee Development Corp (PK) USOTC:ASXSF OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.04154 21.12% 0.23824 0.193 0.3345 0.23824 0.23824 0.23824 1,106 21:00:35

- Notification that Annual Report will be submitted late (NT 10-K)

29/06/2011 4:38pm

Edgar (US Regulatory)


 
UNITED STATES
OMB APPROVAL
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB Number:          3235-0058
Expires:                  May 31, 2012
Estimated average burden
hours per  response . . . . . . . 2.50
     
 
FORM 12b-25
 
SEC FILE NUMBER
001-15975
     
 
NOTIFICATION OF LATE FILING
CUSIP NUMBER
 
 
(Check one) : x  Form 10-K     ¨  Form 20-F     ¨  Form 11-K     ¨  Form 10-Q     ¨  Form 10-D     ¨  Form N-SAR ¨  Form N-CSR
For Period Ended:   March 31, 2011                                                                              
¨       Transition Report on Form 10-K
¨       Transition Report on Form 20-F
¨       Transition Report on Form 11-K
¨       Transition Report on Form 10-Q
¨       Transition Report on Form N-SAR
For the Transition Period Ended: __________________________

Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above identify the Item(s) to which the notification relates:
 

PART I – REGISTRANT INFORMATION

Remedent, Inc.
Full Name of Registrant
 
Former Name if Applicable
 
Zuiderlaan, 1-3 bus 8, 9000
Address of Principal Executive Office ( Street and Number )
 
Ghent, Belgium
City, State and Zip Code

PART II RULES 12b-25(b) AND (c)

If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed.  (Check box if appropriate.)

 
 
 
x
(a)
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;
(b)
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
(c)
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

PART III – NARRATIVE

State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof could not be filed within the prescribed time period.
 
We are filing this Form 12b-25 because we are unable to complete the preparation, review and filing of the our annual report on Form 10-K by June 29, 2011 without unreasonable effort or expense.

SEC 1344 (05-06)
Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
(Attach extra Sheets if Needed)
 
 
 

 

PART IV – OTHER INFORMATION

(1)
Name and telephone number of person to contact in regard to this notification.
 
Guy De Vreese
 
011
 
32-9-431-7080
 
(Name)
 
(Area Code)
 
(Telephone Numb er)
 
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed?  If answer is no, identify report(s).
 
Yes x            No ¨
   
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof ?
 
Yes x          No ¨
   
 
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
 
Remedent, Inc.  (the “Company”) anticipates on reporting an increase of approximately 58% in revenue during year ended March 31, 2011 compared to March 31, 2010.   The Company anticipates on reporting a decrease of approximately 54% in net loss attributable to stockholders for the year ended March 31, 2011 compared to March 31, 2010.  The Company anticipates on reporting that its net income for year ended March 31, 2011 was negatively impacted by (i) a provision of $750,000 for an investment relating to Soca Networks Singapore, and (ii) write off costs of approximately $60,000 relating to patents and royalty for two teeth whitening patents and the Universal Applicator Patent.
 

Remedent, Inc.
(Name of Registrant as specified in its charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.

Date:
June 29, 2011
 
By:
/s/ Stephen Ross
       
Stephen Ross, Chief Financial Officer

INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative.  The name and title of the person signing the form shall be typed or printed beneath the signature.  If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer)
evidence of  the representative’s authority to sign on behalf of the registrant shall be filed with the form.

 
ATTENTION
 
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

GENERAL INSTRUCTIONS

1.
This form is required by Rule 12b-25 (17 CFR 240.12b-25) of the General Rules and Regulations under the Securities Exchange Act of 1934.
   
2.
One signed original and four conformed copies of this form and amendments thereto must be completed and filed with the Securities and Exchange Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the General Rules and Regulations under the Act. The information contained in or filed with the form will be made a matter of public record in the Commission files.
   
3.
A manually signed copy of the form and amendments thereto shall be filed with each national securities exchange on which any class of securities of the registrant is registered.
   
4.
Amendments to the notifications must also be filed on Form 12b-25 but need not restate information that has been correctly furnished.  The form shall be clearly identified as an amended notification.
   
5.
Electronic Filers : This form shall not be used by electronic filers unable to timely file a report solely due to electronic difficulties.  Filers unable to submit reports within the time period prescribed due to difficulties in electronic filing should comply with either Rule 201 or Rule 202 of Regulation S-T (§232.201 or §232.202 of this chapter) or apply for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T (§232.13(b) of this chapter).
 
 
2

 
 

1 Year Elysee Development (PK) Chart

1 Year Elysee Development (PK) Chart

1 Month Elysee Development (PK) Chart

1 Month Elysee Development (PK) Chart

Your Recent History

Delayed Upgrade Clock